The Legal 500

Cravath, Swaine & Moore LLP

WORLDWIDE PLAZA, 825 EIGHTH AVENUE, NEW YORK, NY 10019-7475, USA
Tel:
Work +1 212 474 1000
Fax:
Fax +1 212 474 3700
Email:
Web:
www.cravath.com
New York, London

C. Allen Parker

Tel:
Work +1 (212) 474-1765
Email:
Cravath, Swaine & Moore LLP

Work Department

Corporate.

Position

C. Allen Parker is Cravath’s Presiding Partner. He has extensive experience in a broad range of finance, banking and related matters, including syndicated loan transactions, acquisition financings and leveraged recapitalizations, as well as extensive experience in a broad range of corporate advisory matters. Mr. Parker’s clients have included JPMorgan Chase, Citigroup, Covenant House, DreamWorks Animation, DreamWorks Studios, Kissinger Associates and Permira.

Career

After a clerkship with Hon. Amalya Kearse of the U.S. Court of Appeals for the Second Circuit, Mr. Parker joined Cravath in 1984 and became a partner in 1990. He served as Managing Partner of the Corporate Department from January 2001 to December 2004, as Deputy Presiding Partner from January 2007 to December 2012 and as Head of the Corporate Department from January 2009 to September 2010. In June 2012, Mr. Parker was elected Presiding Partner effective January 1, 2013. He is also the Chair of the Firm’s Diversity Committee.

Mr. Parker has been repeatedly cited as one of the country’s preeminent practitioners in banking and finance by, among others, Chambers USA: America’s Leading Lawyers for Business from 2007 through 2014; Chambers Global: The World’s Leading Lawyers for Business from 2007 through 2014; The Legal 500 from 2007 through 2013; The Best Lawyers in America from 2007 through 2014; Lawdragon’s 500 Leading Lawyers in America; IFLR1000: The Guide to the World’s Leading Financial Law Firms from 2011 through 2014; The International Who’s Who of Banking Lawyers; and PLC Which Lawyer? Recently, Cravath’s banking and finance practice received the highest ranking by Chambers for its “incredible quality of legal advice.”

Member

Mr. Parker is a member of the New York State Bar Association and a member of the New York City Bar Association, where he served on the Corporation Law Committee from 2009 to 2012. He serves on the Board of Visitors for the Columbia University School of Law, the Board of Visitors of the Duke University School of Law and the Board of Trustees of the National Humanities Center. In addition, Mr. Parker is a member of the Board of Directors of the New York Philharmonic, serves as a Vice Chair of the Kennedy Center Corporate Fund Board and is a member of the Board of Directors of the American Society for the Prevention of Cruelty to Animals. He is also a member of the Council on Foreign Relations.

Education

Mr. Parker received a B.A. magna cum laude from Duke University in 1977, an M.A. from the University of Chicago in 1980 and a J.D. magna cum laude from Columbia Law School in 1983, where he was a Harlan Fiske Stone Scholar and Notes and Comments Editor of the Law Review.

Back to index

Legal Developments worldwide

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • China Drug Registration Regulation - Public consultation on amendment closes - March 2014

    In February 2014, the China Food and Drug Administration (“CFDA”) invited second-round comments from the public regarding proposed amendments to the China Drug Registration Regulations (“DRR”). One of the proposed amendments touches upon patent protection for drugs in China.
  • Revised NDRC Measures for Approval and Filing of Outbound Investment Projects - April 2014

    The National Development and Reform Commission ( NDRC ) released a new set of Management Measures for Approval and Filing of Outbound Investment Projects ( 境外投资项目核准和备案管理办法) ( New Measures ) on 8 April 2014. The New Measures take effect on 8 May 2014 and will replace the Interim Management Measures for Approval of Outbound Investment Projects ( 境外投资项目核准暂行管理办法) ( Original Measures ) which have been in force since 9 October 2004.
  • Insurance Update - CIRC Issues Insurance M&A Measures: What are the impacts and applications?

    On 21 March 2014, CIRC issued the Administrative Measures on the Acquisition and Merger of Insurance Companies (the Insurance M&A Measures ) which will take effect from 1 June 2014. The Insurance M&A Measures apply to M&A activities whereby an insurance company is the target for a merger or acquisition. The target insurance company could be either a domestic or a foreign invested insurer. However, the Insurance M&A Measures will not apply to any equity investment by insurance companies in non-insurance companies in China or in overseas insurance companies.
  • China issues new rules to regulate medical devices - May 2014

    The Regulations on Supervision and Administration of Medical Devices (in Chinese《医疗器械监督管理条例》, State Council Order No. 650) (the Medical Device Regulations) were amended by China's State Council on 31 March 2014 and will come into effect on 1 June 2014. This is the first amendment in more than a decade since the Medical Device Regulations were first promulgated in 2000, even though the amendment was initiated eight years ago in 2006. The 2014 amendment unveils reforms on the regulatory regime for medical devices market in China from various aspects.
  • Walking a fine line in China:Distinguishing between legitimate commercial deals and commercial bribe

    China in the 21st century exemplifies an atmosphere of great opportunity and intense competition. Against this backdrop, it has become increasingly common for businesses to adopt a variety of practices in order to make their products and services competitive. Such practices may include paying middle-men to promote sales and giving incentives to buyers directly. However, whilst revenue spikes are undoubtedly welcome, businesses should bear in mind the potential backlash arising out of these commercial arrangements. The risk that such arrangements may not comply with anti-bribery and corruption laws and therefore cause business significant damage in the long term should not be underestimated.
  • Rise of the private healthcare sector - July 2014

    As of 2013, China had 9,800 private hospitals, representing almost half of the total number of hospitals in the country 1 . However, private hospitals still severely lag behind their public peers due to low utilisation, talent shortages and incomplete social insurance coverage. As part of China's ongoing healthcare reform initiatives, the Chinese government has set a goal to increase the share of patients treated by private hospitals to 20% by the end of 2015 2 .
  • Banking regulation in China: Proposed deposit insurance system - December 2014

    On 30 November 2014, the State Council of China released a draft Deposit Insurance Regulation (the Draft), to establish a deposit insurance system in order to "protect interests of depositors, prevent and mitigate financial risks and maintain a stabilised financial system". The public are invited to submit comments on the Draft by 30 December 2014.
  • Tackling bribery: China toughens criminal law - December 2014

    Following earlier reforms of the PRC's anti-corruption rules (for further information, please see our previous briefings published in January 2013 and March 2011 ), the National People's Congress (NPC) has recently published a proposed amendment to the PRC Criminal Law in draft form for public comments (the Draft). The Draft expands the reach of official bribery offences, gives more autonomy to judges to inflict severe punishments, and generally increases the level and type of punishments that can be imposed on individuals who commit bribery offences. It further demonstrates the government's determination to tackle corruption in China.
  • China banking restrictions relaxed: New rules further open banking sector to foreign investors

    The State Council of China recently released amendments to the Foreign Bank Administrative Regulations of China (the Amendments) with effect from 1 January 2015.
  • Walking a Tightrope in Singapore - July 2014

    The world has no borders and distance is negligible for the technologically savvy criminal. Individuals with illicit funds to launder or terrorist activities to finance can, with the latest technology, transfer high volumes of money around the globe almost instantaneously and seek to conceal the origin or the destination of the funds.